ARTV

COM:ARTIVABIO

Artiva Biotherapeutics

  • Stock

Last Close

10.88

22/11 21:00

Market Cap

105.10M

Beta: -

Volume Today

36.36K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
net income
-71.83M
-
-58.79M
18.15%
-28.72M
51.15%
depreciation and amortization
248K
-
1.16M
366.94%
2.27M
95.68%
deferred income tax
stock based compensation
4.31M
-
6.58M
52.87%
7.05M
7.12%
change in working capital
33.41M
-
-3.87M
111.57%
-28.28M
631.51%
accounts receivables
-468K
-
-57K
87.82%
-510K
794.74%
inventory
accounts payables
-1.24M
-
190K
115.27%
-408K
314.74%
other working capital
28.92M
-
-2.38M
108.24%
-26.38M
1,007.05%
other non cash items
18.55M
-
net cash provided by operating activities
-15.30M
-
-50.83M
232.13%
-47.43M
6.69%
investments in property plant and equipment
-1.72M
-
-6.30M
265.37%
-3.26M
48.28%
acquisitions net
purchases of investments
-49.52M
-
sales maturities of investments
26.80M
-
other investing activites
net cash used for investing activites
-1.72M
-
-6.30M
265.37%
-25.98M
312.37%
debt repayment
common stock issued
common stock repurchased
-5K
-
-12K
140%
dividends paid
other financing activites
-2.03M
-
-1.59M
21.74%
net cash used provided by financing activities
152.75M
-
-1.26M
100.83%
24.39M
2,029.67%
effect of forex changes on cash
net change in cash
135.73M
-
-58.39M
143.02%
-49.01M
16.06%
cash at beginning of period
25.44M
-
161.17M
533.47%
102.78M
36.23%
cash at end of period
161.17M
-
102.78M
36.23%
53.76M
47.69%
operating cash flow
-15.30M
-
-50.83M
232.13%
-47.43M
6.69%
capital expenditure
-1.72M
-
-6.30M
265.37%
-3.26M
48.28%
free cash flow
-17.03M
-
-57.13M
235.49%
-50.69M
11.27%

All numbers in (except ratios and percentages)